Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CICLESONIDE Cause Respiratory tract infection? 122 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 122 reports of Respiratory tract infection have been filed in association with CICLESONIDE (Alvesco). This represents 2.1% of all adverse event reports for CICLESONIDE.

122
Reports of Respiratory tract infection with CICLESONIDE
2.1%
of all CICLESONIDE reports
0
Deaths
46
Hospitalizations

How Dangerous Is Respiratory tract infection From CICLESONIDE?

Of the 122 reports, 46 (37.7%) required hospitalization.

Is Respiratory tract infection Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CICLESONIDE. However, 122 reports have been filed with the FAERS database.

What Other Side Effects Does CICLESONIDE Cause?

Asthma (4,026) Dyspnoea (2,953) Wheezing (2,785) Therapeutic product effect incomplete (2,337) Loss of personal independence in daily activities (1,575) Obstructive airways disorder (1,403) Cough (1,395) Sleep disorder due to a general medical condition (1,333) Full blood count abnormal (916) Productive cough (847)

What Other Drugs Cause Respiratory tract infection?

RITUXIMAB (1,058) PREDNISONE (1,051) OMALIZUMAB (927) ADALIMUMAB (913) METHOTREXATE (895) ETANERCEPT (848) HUMAN IMMUNOGLOBULIN G (764) LENALIDOMIDE (731) DEXAMETHASONE (684) ALBUTEROL (601)

Which CICLESONIDE Alternatives Have Lower Respiratory tract infection Risk?

CICLESONIDE vs CICLOPIROX CICLESONIDE vs CICLOPIROX OLAMINE CICLESONIDE vs CICLOSPORIN CICLESONIDE vs CIDOFOVIR CICLESONIDE vs CILASTATIN

Related Pages

CICLESONIDE Full Profile All Respiratory tract infection Reports All Drugs Causing Respiratory tract infection CICLESONIDE Demographics